COLLECTINS IN VAGINAL MUCOSAL HOST DEFENSE
阴道粘膜宿主防御中的集合素
基本信息
- 批准号:6198040
- 负责人:
- 金额:$ 23.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-01 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:candidiasis clinical research cytokine enzyme linked immunosorbent assay female hormone regulation /control mechanism human subject immunocytochemistry lectin mannans menstrual cycle mucosa mucosal immunity phagocytosis protein localization surfactant tissue /cell culture vagina vaginitis women's health
项目摘要
DESCRIPTION (adapted from applicant's abstract): The vaginal mucosa (VM) is
one of the critical interfaces between host and pathogens. Normally, it can
tolerate and contain a broad range of microbes and cope with foreign proteins
including those present in the ejaculate. Hence, VM is likely to be equipped
with an arsenal of defenses similar to that of the other such mucosal
interfaces, e.g., lung and gut. This proposal focuses on vaginitis, a
condition resulting from a breakdown of defenses against organisms that remain
largely localized yet can have major consequences for the host and her
reproductive capacity. Vaginitis is responsible for up to 15% of patient
visits to women's health practices. The sequelae of VM have great effects on
public health, and are implicated in disorders ranging from preterm labor and
associated morbidity and mortality of the offspring, to increased
susceptibility to sexually transmitted disease and progression of cervical
neoplasia. Yet, knowledge of vaginal host defenses has lagged behind that of
other mucosal surfaces. Here we propose to follow up on evidence obtained by
us that SP-A is expressed in VM and is present in VF by testing the hypotheses
that: (1) SP-A in VF, as in lung, contributes to host defenses by modulating
cytokine production and facilitating phagocytosis; (2) SP-A expression in VM
and function in VF, like other mediators of vaginal immunity, vary with
menstrual cycle (i.e., is hormonally regulated); and (3) aberrant SP-A
homeostasis contributes to recurrent vulvovaginal candidiasis (RVVC), a
prevalent, intractable condition of women of reproductive age that is
characterized by episodes of exacerbations of inflammation of the VM due to
colonization of the vagina with C. albicans. Parameters relevant to SP-A
function will be compared: (1) in healthy women at three stages of the
menstrual cycle; (2) in healthy women and RVVC patients; and (3) in RVVC
patients during remissions and exacerbations of the disease. In VM, SP-A will
be localized by immunocytochemistry and gene-specific message levels will be
estimated by reverse transcriptase/polymerase chain reaction (RT/PCR). In VF,
SP-A levels will be measured by enzyme-linked immunoabsorbent assay (ELISA),
SP-A oligomeric size established by gel filtration and ability of SP-A to
stimulate production of proximal cytokines and to facilitate phagocytosis.
This will be accomplished using THP-1 macrophages adapted to grow as
surrogates for vaginal macrophages in a medium that simulates VF fluid with
respect to certain determinants of SP-A function, such as pH, electrolyte and
cation concentrations. Immunodepletion will be used to determine the
contribution made by SP-A to stimulation of cytokine production by TPH-1
cells.
描述(改编自申请人的摘要):阴道粘膜(VM)是
宿主和病原体之间的关键界面之一。 通常情况下,它可以
容忍并包含广泛的微生物,并科普外来蛋白质
包括那些存在于精液中的物质。 因此,VM可能会配备
与其他粘膜类似的防御武器库
接口,例如,肺和内脏 这项建议的重点是阴道炎,
由于抵抗残留有机体的防御系统崩溃而导致的状况
大部分是局部的,但可能对宿主和她的身体产生重大影响。
生殖能力 阴道炎是负责高达15%的病人
参观妇女保健诊所。 VM的后遗症对
公共卫生,并涉及从早产和
相关的发病率和死亡率的后代,以增加
性传播疾病易感性与宫颈癌进展
肿瘤形成 然而,对阴道宿主防御的了解已经落后于
其他粘膜表面。 在此,我们建议对以下方面获得的证据采取后续行动:
通过检验假设,我们认为SP-A在VM中表达,并存在于VF中
(1)VF中的SP-A与肺中的SP-A一样,通过调节
细胞因子的产生和促进吞噬作用;(2)VM中SP-A的表达
和功能,在VF,像其他介质的阴道免疫,不同的
月经周期(即,受神经调节);和(3)异常SP-A
内稳态有助于复发性外阴阴道念珠菌病(RVVC),
育龄妇女普遍存在的顽固性疾病,
其特征是由于以下原因导致VM炎症加剧
阴道内定植C.白色念珠菌。 SP-A相关参数
功能将进行比较:(1)在健康女性的三个阶段,
月经周期;(2)健康女性和RVVC患者;(3)RVVC
在疾病缓解和恶化期间的患者。 在VM中,SP-A将
通过免疫细胞化学和基因特异性信息水平进行定位,
通过逆转录酶/聚合酶链反应(RT/PCR)估计。 在VF中,
将通过酶联免疫吸附试验(ELISA)测量SP-A水平,
通过凝胶过滤确定的SP-A寡聚体大小和SP-A
刺激近端细胞因子产生并促进吞噬作用。
这将使用THP-1巨噬细胞来实现,所述巨噬细胞适于生长为
阴道巨噬细胞的替代物在模拟VF流体的培养基中,
关于SP-A功能的某些决定因素,如pH、电解质和
阳离子浓度 免疫耗竭将用于确定
SP-A对TPH-1刺激细胞因子产生的贡献
细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
COLIN MACNEILL其他文献
COLIN MACNEILL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('COLIN MACNEILL', 18)}}的其他基金
SURFACTANT PROTEIN-LIPID BALANCE: MODULATING LOWER GENITAL TRACT INFLAMMATION
表面活性剂蛋白质-脂质平衡:调节下生殖道炎症
- 批准号:
7951266 - 财政年份:2009
- 资助金额:
$ 23.49万 - 项目类别:
COLLECTIN -MEDIATED INNATE IMMUNITY IN VULVODYNIA
集合素介导的外阴痛的先天免疫
- 批准号:
7378451 - 财政年份:2006
- 资助金额:
$ 23.49万 - 项目类别:
IMMUNE MOD BY VAGINAL SURFACTANT PROTEIN: ROLE IN NORMAL PREGNANCY & PRETERM LAB
阴道表面活性蛋白的免疫调节:在正常妊娠中的作用
- 批准号:
7203520 - 财政年份:2005
- 资助金额:
$ 23.49万 - 项目类别:
Collectin-mediated innate immunity in vulvodynia
外阴痛中集合素介导的先天免疫
- 批准号:
7044381 - 财政年份:2003
- 资助金额:
$ 23.49万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 23.49万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 23.49万 - 项目类别: